Test–retest assessment of non-contrast MRI sequences to characterise and quantify the small bowel wall in healthy participants by Alyami, Ali. S. et al.
Vol.:(0123456789) 
Magnetic Resonance Materials in Physics, Biology and Medicine 
https://doi.org/10.1007/s10334-021-00931-2
RESEARCH ARTICLE
Test–retest assessment of non‑contrast MRI sequences to characterise 
and quantify the small bowel wall in healthy participants
Ali. S. Alyami1,2,3 · Hannah. G. Williams2,3 · Konstantinos Argyriou4 · David Gunn2,4 · Victoria Wilkinson‑Smith2,4 · 
Jonathan. R. White2,4 · Jaber Alyami5 · Penny. A. Gowland3,4 · Gordon. W. Moran2,4 · Caroline. L. Hoad3,4 
Received: 15 March 2021 / Revised: 10 May 2021 / Accepted: 18 May 2021 
© The Author(s) 2021
Abstract
Objective Quantitative Magnetic Resonance Imaging sequences have been investigated as objective imaging biomarkers of 
fibrosis and inflammation in Crohn’s disease.
Aim To determine the repeatability and inter- and intra-observer agreement of these measures in the prepared small bowel 
wall.
Methods Ten healthy participants were scanned at 3 T on 2 separate occasions using T1 and T2 relaxometry, IVIM-DWI 
and MT sequences. Test–retest repeatability was assessed using the coefficient of variation (CoV) and intra-class correlation 
coefficients (ICCs) were used to evaluate the intra- and inter-observer agreement
Results Test–retest repeatability in the bowel wall was excellent for apparent diffusion coefficient (ADC), magnetisation 
transfer ratio (MTR), T1, and diffusion coefficient D (CoV 5%, 7%, 8%, and 10%, respectively), good for perfusion fraction 
(PF) (CoV 20%) and acceptable for T2 (CoV 21%). Inter-observer agreement was good for the T2, D and ADC (ICC = 0.89, 
0.86, 0.76, respectively) and moderate for T1 (ICC = 0.55). Intra-observer agreement was similar to inter-observer agreement.
Discussion This study showed variable results between the different parameters measured. Test–retest repeatability was at 
least acceptable for all parameters except pseudo-diffusion coefficient D*. Good inter- and intra-observer agreement was 
obtained for T2, ADC and D, with these parameters performing best in this technical validation study.
Keywords Small intestine · Multiparametric magnetic resonance imaging · Validation study
Abbreviations
ADC  Apparent diffusion coefficient
CD  Crohn’s Disease
CV  Coefficient of variation
D*  Pseudodiffusion coefficient
D  ‘True’ diffusion coefficient
DWI  Diffusion-weighted imaging
ICC  Intra-class correlation coefficient
IVIM  Intravoxel incoherent motion
MRI  Magnetic Resonance Imaging
MTR  Magnetization transfer ratio
PF  Perfusion fraction
ROI  Region of interest
Introduction
Magnetic Resonance Imaging (MRI) is now a gold-standard 
modality for non-invasively assessing disease activity and 
extent in small bowel Crohn’s disease (CD) [1, 2]. Multiple 
scoring systems have been set up to quantify the disease 
activity from T2-weighted and T1-weighted images [3–5]. 
These scoring systems rely on radiology observations which 
are subjective and time consuming to perform. Clinical 
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T1-weighted and T2-weighted images cannot reliably dif-
ferentiate fibrosis from inflammation in the bowel wall; an 
important determinant in decision-making for treatment 
options.
Recently, quantitative sequences such as diffusion-
weighted imaging (DWI) [6, 7] and magnetisation transfer 
(MT) [8, 9] have been investigated as potential imaging 
biomarkers in CD. Intravoxel incoherent motion imaging 
(IVIM) [10] can provide contrast-free measures of tissue 
perfusion which is related to inflammation. MT reflects the 
exchange of magnetisation between protons in free water 
and protons bound to semisolid macromolecules and other 
moieties, and hence is a potential non-invasive measure of 
collagen deposition and intestinal fibrosis [8, 11–13]. Quan-
titative relaxometry T1 and T2 measures have shown poten-
tial as markers of fibrosis and inflammation in the liver [14, 
15], pancreas [16, 17] and kidneys [18] and T2 of the small 
bowel wall has been shown to be related to intestinal perme-
ability [19]. However, T1 and T2 measures have not been 
widely investigated in intestinal wall imaging.
These quantitative measures may provide an objective 
marker of disease activity which would be valuable in diag-
nosis, and monitoring progression and response to treatment 
[20]. As for most biomarkers, the validation of these imaging 
markers along the biomarker discovery roadmap is incom-
plete. In general, there are early and late phases to this road-
map [21], although there may be overlap between the two. 
The early phase is related to technical and biological valida-
tion which is rarely completed and which tend to be single 
site studies in small cohorts. Technical validation relates 
to repeatability, reproducibility and inter/intra-observer 
variability. Late phase downstream studies consider larger 
biological validation, clinical utility and clinical validation.
There is limited literature investigating the repeatability 
of these quantitative sequences in the small bowel. More-
over, oral preparation required prior to MR enterography 
(MRE) may have an effect on the signal intensity due to 
differential small bowel distension.
This study aimed to measure test–retest repeatability and 
inter/intra-observer agreement in T2, T1, IVIM-DWI and 
MT measurements of the small bowel wall following bowel 
preparation, and administration of an anti-spasmodic agent, 
in healthy participants on a single MRI platform.
Materials and methods
Study design
This was a single-centre prospective study recruiting 
healthy participants. The exclusion criteria included any 
history of gastrointestinal disease, pregnancy, contra-indi-
cations to anti-spasmodic agent usage, and any concomitant 
medication use that according to the investigators may affect 
gastrointestinal transit. The study was approved by the Uni-
versity of Nottingham Medical School Ethics Committee 
(J/3/2007/17) on 18/07/2017. Signed informed consent was 
obtained from all participants prior to recruitment. A subset 
of the T2 data has been reported previously [19].
Ten participants were scanned twice using an identical 
protocol, with a minimum of a two-week interval between 
visits. Participants were asked to fast from 22:00 h the previ-
ous evening, and to avoid ingesting caffeine and alcohol, and 
taking part in strenuous exercise the day prior to the study. 
Forty minutes before scanning, participants were given 
1000 mL of bowel preparation (2.5% mannitol with 0.2% 
locust bean gum), to ingest slowly. After initial planning 
scans, and before the quantitative acquisitions, participants 
were given two separate doses of an anti-spasmodic agent 
(hyoscine butylbromide 20 mg) intravenously. One dose was 
administered before the T2 and DWI measurements, and the 
second dose before the T1 and MT sequence acquisitions 
(Fig. 1).
MRI protocol
Imaging was performed using a 3 T Ingenia scanner (Philips, 
Best, The Netherlands) with participants positioned in a feet-
first prone position. A respiratory belt was placed between 
the participant’s back and the MR coil using a velcro attach-
ment to ensure a stable position, and a good respiratory trace 
for triggered scanning. Sagittal, axial, and coronal localisers 
were obtained to plan the position of the other sequences. 
The quantitative sequence information is given below with 
further details in Table 1.
• T2 data were acquired with a single slice coronal spin-
echo prepared bTFE sequence [22], at six echo times 
(TE). The slice was positioned towards the anterior of 
the body to maximise coverage of small bowel loops.
• IVIM-DWI respiratory triggered data were acquired 
using a single-shot spin-echo echo-planar sequence (SE-
EPI) at 9 b values, over 12 coronal slices, positioned to 
include as much of the small bowel as possible.
• T1 data were acquired from a single coronal slice using 
an inversion recovery prepared TFE sequence positioned 
in the same location as the T2 data. An additional image 
with no inversion was also acquired to provide a measure 
of the equilibirum magnetization.
• MT data were acquired using a saturation prepared 
 (MTon) and standard  (MToff) TFE scan, from a single cor-
onal slice. The two scans were acquired during a single 
breath-hold of 11 s with a gap between the two dynamics 
of each scan. The off-resonance saturation was applied at 
1000 Hz. Data from 2 different slices were acquired with 
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one slice placed towards the anterior of the small bowel 
and the second towards the posterior
MRI Data analysis
All analysis was carried out using a different custom-written 
software for each sequence in MATLAB® (The MathWorks, 
Natick, MA, USA).
T2 Data
The dataset was motion-corrected to remove distortions due 
to respiration and peristalsis [19] using a non-linear inten-
sity-based motion correction algorithm in Matlab®. The 
analysis was performed using a semi-automated program 
which used edge detection and thresholding to isolate the 
bowel wall [19]. The wall was then split into multiple ROIs 
and the signal from each ROI fitted for T2 taking account of 
the effect of the full bTFE readout [22]. A two-compartment 
Fig. 1  Protocol schematic for the repeatability study
Table 1  Parameters of MRI scans
MRI parameters T2 scan T1 scan IVIM-DWI scan MT scan
Sequence Single coronal slice spin-
echo
prepared bTFE
Single slice T1 weighted






Slice thickness (mm) 5 5 5 5
TR/TE (ms/ms) 3.4 / 1.68 10 / 2.3 1278 / 71 20 / 2.3
Field of view  (mm2) 340 × 352 375 × 351 400 × 400 375 × 351
Number of slices 1 1 12 2
Breath-holding (BH) 1 BH per TE value with 
a 15 s gap between TE 
acquisitions
1 BH per TI value with 




11 s BH per slice to cover 
both ‘on’ and ‘off’ reso-
nance image acquisition
Parameter variation TE-prep values: 20, 50, 80, 
120, 180, 300 ms
TI values: 500, 650, 800, 
950, 1000, 1150, 1300, 
2500, 5000 ms
b-values: 0, 50, 100, 200, 
300, 400, 600, 800, 
1000 s/mm2
Presaturation MT on /off 
pulse
Approximate scan time 
including waiting 
between BH (mins)
2 3–4 4–6 1
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model was used to overcome partial volume effects (small 
bowel wall and content). Figure 2 shows an example of the 
small bowel mask created using the software. The observer 
interacted with the software for approximately 2 min per 
subject study visit to generate the ROIs signal for fitting. The 
automatic motion correction section of the algorithm took 
around 5 min to run per subject study visit.
T1 Data
ROIs were drawn along the bowel on the shortest inver-
sion recovery image. These ROIs were then applied to the 
remaining images and moved rigidly to account for any 
motion that occurred throught the aquistion. ROIs were also 
drawn in the contents of the bowel. First, the mean signal 
from the content ROIs was fitted to an inversion recovery 
model including a parameter to take account of the degree of 
inversion (α), using the least-squares non-linear curve-fitting 
algorithm in Matlab®. Next, the wall data were fitted to 
a similar two compartment inversion recovery model, but 
this time including the T1 and α for the contents from the 
previous fit, to allow for partial volume effects in the ROI to 
be taken into account. The process was repeated for several 
bowel wall ROIs, with the aim to define a minimum of 10 
different ROIs per image. The time taken to complete each 
ROI (including fitting the data) was between 2 and 5 min 
depending on how much motion correction to the ROI was 
needed.
MT Data
MTR values were determined from ROIs of the mean signal 
intensity in the MT data. ROIs were defined using custom-
written software in Matlab® following several steps. First, 
a region of the image containing small bowel was selected 
(Fig. 3a) and rigid-body motion correction was applied 
Fig. 2  An example image 
highlighting the bowel wall that 
is automatically selected using 
a combination of thresholding 
and edge detection to define the 
walls. (A) T2 weighted bTFE 
image (TE = 20 ms). (B) Mask 
of the small bowel wall (red) 
overlaid on the TE = 20 ms 
image
Fig. 3  An exmaple of ROI definition on MT images. The ROI was 
drawn on the small bowel wall after motion correction of the images. 
a shows the raw MT-on image with cropped area highlighted which 
was the target for motion correction. b Cropped area after motion cor-
rection. c MTR image with the bowel wall ROI highlighted
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between the  MTon and  MToff data for that region using an 
intensity-based algorithm. An MTR map  (MTon-MToff)/
MToff was calcuated across the region. The MTR map was 
used to determine whether the small bowel wall had visually 
improved after the motion correction applied. Improvement 
was defined as the wall edges being sharper and the walls 
thinner visually on the MTR image. Obvious wall movement 
between the on and off data was also checked visually. If 
large scale motion, seen between the on and off original data, 
was not corrected using motion correction, a new region was 
selected. Motion correction was not always optimal due to 
the change in contrast between the bowel wall and contents 
across the two different MT images. If the images (either 
original data or motion corrected) were deemed accept-
able for analysis, the ROI was then drawn on the selected 
MTR image. The MTR value calculated for the ROI was 
the median of the data. This process was repeated multiple 
times to acquire multiple regions. An example showing the 
MT ROI definition is shown in Fig. 3. The time taken to 
complete each ROI (after the motion correction which took 
approximately 1 min) was between 1 and 2 min.
IVIM‑DWI Data
Initially, an intensity-based rigid-body motion correction 
was run on a small section of the image containing small 
bowel; however, if this did not visually improve the align-
ment of the data and no obvious wall motion was present, 
then the raw data images were used to define the ROIs. An 
ROI was drawn on the bowel wall, and was moved rigidly 
between different b-value images if necessary. The mean 
signal intensity values from all b-value data were then cal-
culated from the ROI, and this process was repeated multiple 
times for different bowel wall ROIs. A two-step process was 
used to fit the data [23] to the IVIM [24] equation given 
below
where  Si is the signal intensity for b-value  bi,  S0 the signal 
intensity for b = 0 s/mm2, PF is the perfusion fraction, D 
the tissue diffusion coefficient and D* the pseudo-diffusion 
coefficient (related to capillary perfusion). First, the diffu-
sion coefficient (D) and and perfusion fraction (PF) were 
estimated using data with b-values larger than 200 s/mm2, 
from the mono-exponential fit of
as at high b-values the first term in Eq. (1) approximates 
to zero. Second, these results for D and PF were used as the 
initial estimate of those parameters in a non-linear fit to the 
full equation, which also evaluates D* using data from all 
(1)












b-values [10]. The time taken to complete each ROI (includ-
ing fitting the data) was between 2 and 5 min depending on 
how much motion correction to the ROI was needed. The 
rigid body motion correction also took around 3–5 min to 
run for each small section.
Test–Retest repeatability and inter-observer and intra-
observer agreement analysis.
The participants were scanned twice in two weeks to 
assess repeatability. Two observers independently anaylsed 
the MT, T2 and T1 (AA—2 years SB MRI experience, 
HW—3 years SB MRI experience) and IVIM-DWI (AA, 
CH—10 + years SB MRI experience) data. Results from 
observer AA were used to evaluate test–retest repeatabil-
ity. The results from both observers were used to evaluate 
inter-observer agreement. Both observers then repeated the 
measurements for intra-observer agreement, a minimum of 
three months seperated the repeated analysis.
Statistical analysis
For all the parameters measured, the median value across 
all ROIs drawn from each visit or analysis were used for the 
subsequent statistical analysis. For descriptive statistics, the 
data were assumed to be non-parametric due to the small 
number of participants in the study and data were expressed 
as median, and interquartile range (IQR).
The coefficient of variation (CoV%) was used as a meas-
ure of test–retest repeatability. The CoV % was computed as 
the percentage of the standard deviation (SD) of the mean 
(SD*100%/mean) calculated from Visit 1 and Visit 2 data 
for each participant individually, and then averaged across 
all participants. The repeatability of each parameter was 
defined as poor when CoV was > 30%, acceptable when CoV 
was between 20 and 30%, good when CoV was between 10 
and 20%, and excellent when CoV ≤ 10% [25]. To assess 
the spread in the data across all the participants (biological 
variation), a CoV was measured across Visit 1 (observer 1) 
data from all participants (sd across all Visit 1 participants’ 
data*100%/mean across all Visit 1 participant data). This 
across-participant data were compared with the within-par-
ticipant data to determine whether the test–retest variability 
was lower than the variation seen across participants.
The intra and inter-observer agreement was assessed by 
calculating the intra-class correlation (ICC) with a two-way 
mixed model of absolute agreement and was interpreted as 
follows: values less than 0.5 were indicators of poor agree-
ment, values between 0.5 and 0.75 were indicators of moder-
ate agreement, values between 0.75 and 0.9 were indicators 
of good agreement, and values greater than 0.90 indicated 
excellent agreement [26]. In addition to the CoV and ICC 
calculations, Bland–Altman plots were used to assess agree-
ment for the test–retest data and observer measurements[27, 
28].
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Statistical analyses were performed using SPSS version 
25 (IBM Armonk, NY) or GraphPad Prism version 8.0 for 
Windows (GraphPad Software, La Jolla California USA).
Results
Participants’ characteristics
Ten participants were screened and recruited. All partici-
pants (9 female, 1 male: mean age 30 ± 8 yrs) completed 
both scans. Two participants were excluded from T2 data 
analysis by both observers due to observed through plane 
motion which caused the bowel to move out of the imaging 
slice during the acquistion. One participant was removed 
from the T1 analysis due to the same reason from one 
observer, and four from the second observer. Figures 4 and 
5 show example images for T1 and T2 data, respectively.
Test–retest repeatability
Table  2 shows that the test–retest repeatability from 
the CoV analysis was excellent for ADC, MTR, T1 and 
D, good for PF, acceptable for T2, and poor for D*. 
Graphic illustration of the test–retest repeatability using 
Bland–Altman plots are shown in Fig. 6, with limits of 
agreement less than 30% of average for MTR and ADC, 
between 30 and 50% of average for T1 and D and greater 
than 50% for T2, PF and D*.
The within participant test–retest CoV data showed lower 
variability when compared to the CoV measured across all 
participants at visit 1 for all parameters except T2.
Inter‑observer agreement
Table 3 shows the ICC for the inter-observer variability, 
along with the Bland–Altman limits of agreement. The 
median number of ROIs used to generate each measurement 
Fig. 4  Single slice coronal images of the abdomen showing the T1 recovery of the bowel wall with different TIs in ms
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are also presented. Inter-observer variability was good for 
T2, D and ADC, moderate for T1 and poor for MTR, PF and 
D*. The correlation graphs for this data are shown in Fig. 7.
Intra‑observer agreement
Table 3 also shows the ICC for the intra-observer agreement 
from 2 separate measurements of the data. Intra-observer ICC 
agreement for observer 1 was excellent in the bowel wall for 
Fig. 5  Single slice coronal image of the abdomen showing T2 decay of the bowel wall with different TEs in ms
Table 2  Test–retest repeatability, mean coefficients of variation 
(CoVs), Bland–Altman limits of agreements (BA-LA) and Intra-class 
correlation coefficients (ICC) of T2, T1, MTR, ADC, D, PF and D* 
parameters. CoVs across all participants calculated from Observer 1 
Visit 1 data is also presented to indicate the variations in the param-
eters across the different participants




Parameter N Visit 1 Median (IQR) Visit 2
Median (IQR)
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0.178, p = 0.310
(-0.522 – 0.712)
50
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Fig. 6  Bland–Altman plots showing test–retest repeatability (% Difference vs average) for all measured quantitative parameters calculated from 
the small bowel MRI scans. Dotted lines indicate the bias (central line) and Dashed lines the corresponding 95% limits of agreement
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Table 3  Inter- and Intra-observer agreement intra-class correlation 
coefficients (ICCs) and Bland–Altman (BA) Bias and limits of agree-
ments (LA) of the measured parameters. The number of measure-
ments for each set of data is given by N. The median (IQR) number 
of ROIs used for each measurement are also given















16 86 (51–165) 105
(68–177)




16 12 (10–12) 10 (10–10)
































20 5 (4–7) 13 (11–15)





ICC [95% CI] Bias
BA-LA
T2 (s) 8 0.067 (0.054–0.083) 0.060 (0.051–0.084) 0.91 [0.65–0.98] 0.002 
[− 0.010–
0.015]
T1 (s) 9 1.0 (0.90–1.0) 0.95 (0.8–2-1) 0.33 [− 0.40–0.80] 0.033 [− 0.24–
0.31]









10 2.4 (2.02–2.72) 2.6 (2.07–2.82) 0.83 [0.47–0.95] − 0.08 
[− 0.72–
0.56]





10 20 (12–32) 21 (12–32) 0.22 [−0.42–0.72] 3.8 [− 19–26]
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T2, good for D and ADC and poor for T1, MTR, PF and D*. 
Observer 2’s data produced similar results (data not presented). 
Correlation data are shown graphically in Fig. 7.
Discussion
The main goal of this study was a technical validation of 
Fig. 7  Correlation graphs for all the measured MRI parameters showing the Test–Retest, Inter- and intra-observer data
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MRI-based quantitative measures of T1 and T2, MTR and 
IVIM-DWI in the small bowel wall on a 3 T MRI platform. 
Test–retest data provide a measure of how repeatable the test 
situation and subsequent analyses are to generate a stable 
measurement of interest, whereas inter- and intra-observer 
agreement provide data on the variability in a single obser-
vation for one or multiple observers. For this study, all 
healthy participants were studied on the same MRI scanner 
by the same experimental team following the same protocol. 
We have shown that the test–retest repeatability CoV was 
excellent for ADC, MTR, T1 and D, good for D, and accept-
able for T2, but poor for D*. In addition the Bland–Altman 
limits of agreement were less than 30% for MTR and ADC, 
but were more than 50% of the average for T2, PF and D*. 
Regarding the inter-observer agreement, ICC was good for 
T2, D and ADC, moderate for T1, while poor for MTR, 
PF and D*. Similar intra-observer variability for T2, D and 
ADC was good to excellent, while poor for MTR, PF and 
D*. However, ICC is partly dependent on the dynamic range 
of the data measured; with small dynamic ranges potentially 
showing less correlation;T1 and MTR had variations of 11 
and 13% across participants, the lowest of all parameters 
measured.)
Test–retest relaxometry data in other organs have shown 
smaller CoV data, with T1 in the liver at 1.8% [15] and kid-
ney 2% [29]. T2 in the extraocular muscles was found to be 
of the order of 2–5% [30]. These are all considerably lower 
than our data. However, whole organ measurements (liver 
and kidney) are expected to be much more repeatable data 
since it is easier to define ROIs in larger organs and these are 
all less sensitive to small movements. Furthermore, it will be 
easier to ensure the same region is sampled between scans 
in the larger organs, which was difficult here, where a single 
slice was acquired across the bowel wall so that different 
parts of bowel may have been sampled for the test–retest 
study. In the cervical spinal cord, Levy et al. [31] showed 
poor ICCs for MTR ranging from -0.3 to 0.4 for different 
vertebral levels for their test–retest data from 16 subjects, 
whereas the data from our study were at the upper end of 
this range at 0.3. The IVIM-DWI measures showed similar 
repeatability when compared to other organs, with ADC and 
D having lower CoV compared to PF and D*. Liver hepato-
cellular carcinomas produced test–retest CoVs of 15.6% and 
19.7% for ADC and D, respectively [25], higher than those 
measured in this study. However, similar values to this study 
were found in the kidney [29], with 2.9%, 9.5% and 39% for 
ADC, D and D* respectively, compared to 5, 10 and 31% for 
the same paramaters in the bowel wall. These results may 
reflect a better multi-slice sampling across the whole bowel 
used for DWI compared to the other quantitative measures.
In terms of inter and intra-observer agreement, T2, which 
used the most automated procedure for ROI definition, pro-
duced the highest agreement between measurements. MTR 
required manual definition of the ROIs which increased vari-
ability and sensitivity to partial volume effects that could not 
be overcome in the same way as for T1 and T2 meaurments 
(which used two compartment fits). In addition, poor breath-
holding and bowel motion would introduce more noise into 
the 2-point measurement, which may have been smoothed 
out if using a curve-fitting approach. Variation in B1 and B0 
field effects could also influence the measured MTR; these 
problem could be addressed somewhat in future by acquiring 
data at a variety of saturation powers and frequency offsets 
(z-spectra). ADC and D showed good observer agreement, 
but PF and D* showed poor agreement, which is similar to 
previous studies in the liver [25] and may reflect the limited 
number of low b-values used [32].
Other studies have measured some of these quantitative 
measurements in the small bowel wall and the data from 
this study agree well with the previously published literature 
for T2 and MTR. The placebo arm of a healthy volunteer 
provocation study [19] measured the T2 of the bowel wall in 
16 subjects with a mean (sd) of 0.070 (0.036) s compared to 
this study which measured a median 0.067 s from the 8 vol-
unteers’ visit 1 data. MTR was measured in both fibrotic and 
healthy appearing tissue from Crohn’s disease patients by 
Pazahr et al. [11]. They measured a mean (sd) MTR of 25.4 
(3.4)% in the healthy tissue compared to 35.3 (4.0) % in the 
fibrotic tissue. The range of the MTR measured in healthy 
appearing tissue was large (17–32%) [11], with the data from 
this study having a median of 29% and smaller total range 
of values across both visits (23–32%), which may be due to 
the multiple ROI measurements carried out for this study 
reducing the overall variability. Several studies have inves-
tigated IVIM parameters in normal or non-fibrotic appear-
ing bowel wall in Crohn’s disease patients [6, 33, 34]. The 
median ADC, D and D* measured in this study were slightly 
higher than those measured in Crohn’s studies (ADC 2.7 
(0.5) and D 1.7 (0.7) ×  10−3mm2/s of Freimann et al. [33], 
with slightly lower values recorded by Hectors et al. [6]). 
This may reflect some partial volume effects of the luminal 
content from the thin bowel wall in healhty volunteers, along 
with differences in b-values used to calculate the parameters. 
The range and median PF values measured in the different 
studies [6, 34] were similar when compared to this study 
(median/mean values around 0.4). To date, there have been 
no previous publications of measuring T1 in the bowel wall.
All quantitative measurements in the bowel present tech-
nical challenges. The bowel must be distended using oral 
contrast, which can result in uneven distension of the wall 
influencing the MRI parameters measured. Bowel motion 
must be eliminated for accurate quantification, which limits 
the maximum experimental length due to the short biologi-
cal half-life of anti-spasmodics available [35]. This limits 
the amount of data that can be acquired for quantification 
(number of TI/TE/b-values used, coverage across the bowel), 
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which will influence the overall repeatability of the measure-
ment. Thin slices, to reduce partial volume effects across the 
walls also increase the likelihood of through plane motion 
further degrading the data.
The technique of magnetic resonance fingerprinting 
allows for rapid simultaneous measurements of T1 and 
T2 [36]. This technique was developed in the brain, and 
due to additional challenges of large scale B1 and B0 inho-
mogeneties and respiratory motion, has only recently been 
applied in the abdomen and pelvis [37–40]. Promising 
results for solid organs (e.g. liver, kidney [37], pancreas 
[39]) have been obtained; however, it has yet to be applied 
in the bowel. This may be because in-plane resolution for 
adequate bowel wall delineation may be difficult to achieve 
during the breath-hold scans currently required. Higher 
resolution and combined diffusion scans have been applied 
in the pelvis where breathholding is not an issue [40].
Our study had some limitations. We included a rela-
tively small number of participants to this study due to 
the need for oral bowel preparation and administration of 
anti-spasmodics. Some data were also lost due to through-
plane motion of the bowel between the different acquisi-
tions of the T1 and T2 data and as the decision to reject 
data for motion was an observer task for T1 there were 
discrepancies between the observers as to which data to 
exclude. A 3D approach to data acquisition and a more 
automated approach to identify large scale motion would 
reduce the amount of data with these errors and discrepan-
cies between observers. Most of the data analyses involved 
manual drawing of the ROIs, which added noise to the 
measurements from both the individual ROI defined and 
the placement of the ROIs along the bowel wall. These two 
factors probably provided most of the differences between 
the 2 observers. Only the IVIM data were derived from a 
large number of slices covering the majority of the small 
bowel. This was not the case in T2, T1 and MTR, and so 
the results are not directly comparable between measures. 
Expanding the measurements to multiple slices or 3D 
acquisition would be one way to overcome this particular 
limitation. The performance of some of these measures 
may be improved in diseased tissue where wall thickness 
is increased and motility reduced.
In conclusion, our study assessed the repeatability of 7 
quantitative parameters in the assessment of small bowel 
walls and measured the observer agreement. In the bowel 
wall, test–retest repeatability was excellent for ADC, D, 
MTR, T1, good for PF, and acceptable for T2, but was poor 
for D*, whereas the inter- and intra-observer agreement 
was good for T2, ADC and D. Overall, T2, ADC and D 
performed best for the methods and scan times used in this 
technical validation study. Further studies are needed to 
investigate the aetiology of the changes observed in these 
parameters to fully understand their role and potential use 
in the small bowel wall. Moroever, 3D or multiple slice 
imaging and more automated analyses will invariably 
decrease bias and variability within these readouts.
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